Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
Wiener Klinische Wochenschrift
|
March 10, 2001
[Pacemaker dysfunction in the clinical practice]
A Geppert, F Rauscha
Klinische Wochenschrift
|
September 1, 1988
[Prevalence of plasma factor deficiency in the Vienna population. Results of a screening study of 1,300 adults]
H Sinzinger, J Flores, F Rauscha
Prostaglandins, Leukotrienes, and Medicine
|
September 1, 1987
Platelet function and prostaglandins in patients with peripheral vascular disease treated with calcium dobesilate
H Sinzinger, F Rauscha, H Vinazzer
American Journal of Hypertension
|
February 1, 1991
Effects of isradipine on platelet function in hypertension at rest and during exercise
P Fitscha, I Virgolini, F Rauscha, et al.
Wiener Klinische Wochenschrift
|
November 4, 1988
[Defects in the prostaglandin system. VI. Acquired plasma factor defect]
H Sinzinger, P Fitscha, F Rauscha, et al.
British Journal of Clinical Pharmacology
|
March 1, 1992
Prostaglandin I2 and the nitric oxide donor molsidomine have synergistic effects on thromboresistance in man
H Sinzinger, F Rauscha, J O'Grady, et al.
Basic Research in Cardiology
|
November 1, 1988
Beneficial effect of PGI2 on circulating endothelial cells
H Sinzinger, F Rauscha, P Fitscha, et al.
American Journal of Hematology
|
February 1, 1990
Prevalence of a shortened prostacyclin half-life in plasma in healthy adults: results of a screening investigation
H Sinzinger, F Rauscha, P Fitscha, et al.
Thrombosis Research
|
March 1, 1992
Ticlopidine and platelet function in healthy volunteers
A Dembinska-Kiec, I Virgolini, F Rauscha, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
March 1, 1989
Glucocorticoid-treatment does not influence the synthesis of thromboxane B2 and bicyclo-PGE2 in humans
H Sinzinger, I Virgolini, F Rauscha, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
Wiener Klinische Wochenschrift
|
March 10, 2001
[Pacemaker dysfunction in the clinical practice]
A Geppert, F Rauscha
Klinische Wochenschrift
|
September 1, 1988
[Prevalence of plasma factor deficiency in the Vienna population. Results of a screening study of 1,300 adults]
H Sinzinger, J Flores, F Rauscha
Prostaglandins, Leukotrienes, and Medicine
|
September 1, 1987
Platelet function and prostaglandins in patients with peripheral vascular disease treated with calcium dobesilate
H Sinzinger, F Rauscha, H Vinazzer
American Journal of Hypertension
|
February 1, 1991
Effects of isradipine on platelet function in hypertension at rest and during exercise
P Fitscha, I Virgolini, F Rauscha, et al.
Wiener Klinische Wochenschrift
|
November 4, 1988
[Defects in the prostaglandin system. VI. Acquired plasma factor defect]
H Sinzinger, P Fitscha, F Rauscha, et al.
British Journal of Clinical Pharmacology
|
March 1, 1992
Prostaglandin I2 and the nitric oxide donor molsidomine have synergistic effects on thromboresistance in man
H Sinzinger, F Rauscha, J O'Grady, et al.
Basic Research in Cardiology
|
November 1, 1988
Beneficial effect of PGI2 on circulating endothelial cells
H Sinzinger, F Rauscha, P Fitscha, et al.
American Journal of Hematology
|
February 1, 1990
Prevalence of a shortened prostacyclin half-life in plasma in healthy adults: results of a screening investigation
H Sinzinger, F Rauscha, P Fitscha, et al.
Thrombosis Research
|
March 1, 1992
Ticlopidine and platelet function in healthy volunteers
A Dembinska-Kiec, I Virgolini, F Rauscha, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids
|
March 1, 1989
Glucocorticoid-treatment does not influence the synthesis of thromboxane B2 and bicyclo-PGE2 in humans
H Sinzinger, I Virgolini, F Rauscha, et al.
Page
of 4